Options Trading News

April 16, 2013  Tue 7:32 AM CT

Europe, Emerging Markets Strong

Coca-Cola earned $0.46 a share in the first quarter on revenue of $11.04 billion. Analysts had only expected $0.45 and $10.94 billion, respectively. Management cited strong demand in Europe and emerging markets. KO advances almost 4 percent before the bell on my tradeMONSTER platform.

FDA Request Sends Sarepta Lower

The Food and Drug Administration asked Sarepta Therapeutics for additional information on its eteplirsen drug for the treatment of Duchenne muscular dystrophy. The summaries requested are to come from the existing data and won't require new research, but SRPT is still down by almost 7 percent in early trading.

Weak Admissions, Outlook Hurt HCA

Hospital operator HCA Holding warned that first-quarter revenue was only $8.44 million, less than the $8.63 billion number expected by analysts. Management cited weak admissions and outpatient levels. HCA drops 3 percent.
Share this article with your friends

Related Stories


Coca-Cola gets show of support

September 17, 2015

The soft-drink maker has struggled with slow volume growth and weak foreign currencies, and shares are trying to hold their lowest levels since early 2014.



The fastest money in the market
View full report »

Premium Services

Archived Webinar

Education & Strategy

The covered call and unhedged risk

I have written a few things on the Covered Call Strategy over the last two weeks. Please understand that those two previous articles plus this one do not constitute a proper, fully in-depth lesson on the Covered Call Strategy like we have in our classes at Option Monster Education. I have picked out a few topics that I believe were worth noting and today I am going to add the final one.

View more education articles »